Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Is It Safe to Correct Iron Deficiency Anemia with Intravenous Iron in Pregnancy? a Systematic Review and Meta-Analysis

Anjali Sachdeva, Pauline Manuel, Teruko Kishibe, Michael Fralick, Nicole M. Kuderer, Grace Tang, Michelle Sholzberg

Blood (2024) 144 (Supplement 1): 5262.

https://doi.org/10.1182/blood-2024-206588

Published: 2024

Journal Articles

Systematic Review, Meta-Analysis, and Quality Appraisal of Advanced Machine Learning Risk Models for Cancer-Associated Thrombosis: The Emergence of Artificial Intelligence in Thrombosis Research

Nicole M. Kuderer, Gary H. Lyman

Blood (2024) 144 (Supplement 1): 4025.

https://doi.org/10.1182/blood-2024-211153

Published: 2024

Journal Articles

Financial Toxicity and Time Toxicity in Multiple Myeloma: Prevalence, Predictors, and Impact on QOL

Rahul Banerjee, Andrew J. Cowan, Marivel Chavez-Ortega, Paul A Carpenter, Masumi Ueda Oshima, Rachel B. Salit, Phuong T Vo, Catherine J. Lee, Rohtesh S. Mehta, Nicole M. Kuderer, Veena Shankaran, Stephanie J. Lee, Christopher T. Su

Blood (2023) 142 (Supplement 1): 2386.

https://doi.org/10.1182/blood-2023-174554

Published: 2023

Journal Articles

High Prevalence of Subjective Minimizing Language in Clinical Trials of Hematologic Malignancies: Natural Language Processing (NLP) Validation Study and Systematic Review of Randomized Controlled Trials Presented at ASH 2009-2021

Benjamin Chin-Yee, Tiancheng Hu, Clarissa Skorupski, Sarah Ghnaim, Bishal Gyawali, Turab Mohammed, James Yu, Gary H. Lyman, Michelle Sholzberg, Lisa Hicks, Nicole M. Kuderer

Blood (2023) 142 (Supplement 1): 3709.

https://doi.org/10.1182/blood-2023-180132

Published: 2023

Journal Articles

Inconsistent Adverse Event Reporting: A Systematic Review of Phase 3 Lymphoma or Myeloma Trials Presented at ASH Annual Meetings between 2017-2021

Clarissa Skorupski, Turab Mohammed, Benjamin Chin-Yee, Bishal Gyawali, Gary H. Lyman, Nicole M. Kuderer, Lisa K. Hicks

Blood (2022) 140 (Supplement 1): 5060–5061.

https://doi.org/10.1182/blood-2022-162981

Published: 2022

Journal Articles

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis

Samuel Rubinstein, MD, Ryan C. Lynch, MD, Aakash Desai, MD, Catherine Stratton, MPH, Alokkumar Jha, PhD, Ziad Bakouny, MD MSc, Andrew Schmidt, MD, R. Alejandro Sica, MD, Divaya Bhutani, MD, Dimpy P. Shah, MD PhD, Sarah A Wall, MD, Gary H. Lyman, MD, Nicole M. Kuderer, MD MSc, Matthias Weiss, MD PhD, Jeremy L. Warner, MD MS, Keith E. Stockerl-Goldstein, MD, Ruben Mesa, MD, Michael A. Thompson, MD PhD

Blood (2020) 136 (Supplement 1): 28–30.

https://doi.org/10.1182/blood-2020-141937

Published: 2020

Journal Articles

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

Blood (2020) 136 (Supplement 1): 56–58.

https://doi.org/10.1182/blood-2020-138834

Published: 2020

Journal Articles

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Christine G. Kohn, PharmD, Gary H. Lyman, MD MPH, Nicole M. Kuderer, Thomas J. Bunz, PharmD, PhD, Craig I. Coleman, PharmD

Blood (2019) 134 (Supplement_1): 3673.

https://doi.org/10.1182/blood-2019-128581

Published: 2019

Journal Articles

Cancer Associated Thrombosis Is Associated with Higher Mortality across All Khorana Score Risk Levels

Alok A Khorana, MD, Keith R McCrae, MD, Nicole M. Kuderer, Dejan Milentijevic, François Laliberté, Guillaume Germain, MSc, Sean D. MacKnight, Patrick Lefebvre, Gary H. Lyman, MD MPH, Michael B. Streiff, MD

Blood (2019) 134 (Supplement_1): 1143.

https://doi.org/10.1182/blood-2019-129090

Published: 2019

Journal Articles

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Ang Li, MD, Josh J Carlson, PhD, Nicole M. Kuderer, Jordan K Schaefer, MD, Shan Li, PharmD, David A. Garcia, MD, Alok A Khorana, MD, Marc Carrier, MD, Gary H. Lyman, MD MPH

Blood (2019) 134 (Supplement_1): 4669.

https://doi.org/10.1182/blood-2019-127917

Published: 2019

Journal Articles

The Rate of Venous Thromboembolism in Cancer Patients Varies By Khorana Risk Category

Alok A. Khorana, MD, Nicole M. Kuderer, MD, Keith R. McCrae, MD, Dejan Milentijevic, PhD, Guillaume Germain, MA, François Laliberté, MA, Nguyen Le, BSc, Patrick Lefebvre, MA, Gary H. Lyman, MD MPH, FRCP, Michael B. Streiff, MD

Blood (2018) 132 (Supplement 1): 3798.

https://doi.org/10.1182/blood-2018-99-116224

Published: 2018

Journal Articles

Healthcare Costs in Patients with Cancer Increase with Increasing Risk of Venous Thromboembolism

Michael B. Streiff, MD, Keith R. McCrae, MD, Nicole M. Kuderer, MD, Dejan Milentijevic, PhD, Guillaume Germain, MA, François Laliberté, MA, Nguyen Le, BSc, Patrick Lefebvre, MA, Gary H. Lyman, MD MPH, FRCP, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 3799.

https://doi.org/10.1182/blood-2018-99-117121

Published: 2018

Journal Articles

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

Blood (2018) 132 (Supplement 1): LBA-1.

https://doi.org/10.1182/blood-2018-120738

Published: 2018

Journal Articles

A Meta-Analysis of the Prognostic Accuracy of Clinical Prediction Rules for Post-Pulmonary Embolism Mortality in Patients with Cancer

Jonathan Caranfa, PharmD, Christine G. Kohn, BS, PharmD, Gary H. Lyman, MD MPH, FRCP, Nicole M. Kuderer, MD, Catherine Stirbis, BS, Mark Wysocki, PharmD, Craig I. Coleman, PharmD, Erin R Weeda, PharmD, Elaine Nguyen, PharmD

Blood (2017) 130 (Supplement 1): 2105.

https://doi.org/10.1182/blood.V130.Suppl_1.2105.2105

Published: 2017

Journal Articles

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Gary H. Lyman, MD MPH, Eva Culakova, PhD MS, Marek S. Poniewierski, MD MS, MS, Nicole M. Kuderer, MD

Blood (2016) 128 (22): 4751.

https://doi.org/10.1182/blood.V128.22.4751.4751

Published: 2016

Journal Articles

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Davendra P. S. Sohal, MD MPH, Nicole M. Kuderer, MD, Frances A. Shepherd, MD FRCPC, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Gary H. Lyman, MD MPH, Alok A. Khorana, MD

Blood (2016) 128 (22): 1422.

https://doi.org/10.1182/blood.V128.22.1422.1422

Published: 2016

Journal Articles

Application of a Validated Predictive Model for Venous Thromboembolism in Cancer to Patients with Multiple Myeloma

Natasha Catherine Edwin, MD, Jesse Keller, MD, Suhong Luo, MS, Kenneth R Carson, MD, Brian F. Gage, MDMSc, Nicole M. Kuderer, MD, David Calverley, MD, Kristen M. Sanfilippo, MD

Blood (2016) 128 (22): 534.

https://doi.org/10.1182/blood.V128.22.534.534

Published: 2016

Journal Articles

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Nicole M. Kuderer, MD, Marek S. Poniewierski, MD MS, MS, Eva Culakova, PhD MS, Gary H. Lyman, MD MPH, Alok A. Khorana, MD, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Frances A. Shepherd, MD FRCPC

Blood (2016) 128 (22): 3590.

https://doi.org/10.1182/blood.V128.22.3590.3590

Published: 2016

Journal Articles

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Gary H. Lyman, MD MPH, Eva Culakova, PhD MS, Marek S. Poniewierski, MD MS, Nicole M. Kuderer, MD

Blood (2014) 124 (21): 2613.

https://doi.org/10.1182/blood.V124.21.2613.2613

Published: 2014

Journal Articles

Risk Score For Venous Thromboembolism (VTE) In Ambulatory Patients: Impact Of Cancer Type and Risk Score On VTE Incidence, Early Mortality and Progression-Free Survival

Nicole M. Kuderer, MD, Alok A. Khorana, MD, Charles Francis, Eva Culakova, PhD, MS, Gary H. Lyman, M.D., M.P.H.

Blood (2013) 122 (21): 3597.

https://doi.org/10.1182/blood.V122.21.3597.3597

Published: 2013

NARROW

Is It Safe to Correct Iron Deficiency Anemia with Intravenous Iron in Pregnancy? a Systematic Review and Meta-Analysis

Systematic Review, Meta-Analysis, and Quality Appraisal of Advanced Machine Learning Risk Models for Cancer-Associated Thrombosis: The Emergence of Artificial Intelligence in Thrombosis Research

Financial Toxicity and Time Toxicity in Multiple Myeloma: Prevalence, Predictors, and Impact on QOL

High Prevalence of Subjective Minimizing Language in Clinical Trials of Hematologic Malignancies: Natural Language Processing (NLP) Validation Study and Systematic Review of Randomized Controlled Trials Presented at ASH 2009-2021

Inconsistent Adverse Event Reporting: A Systematic Review of Phase 3 Lymphoma or Myeloma Trials Presented at ASH Annual Meetings between 2017-2021

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Cancer Associated Thrombosis Is Associated with Higher Mortality across All Khorana Score Risk Levels

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

The Rate of Venous Thromboembolism in Cancer Patients Varies By Khorana Risk Category

Healthcare Costs in Patients with Cancer Increase with Increasing Risk of Venous Thromboembolism

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

A Meta-Analysis of the Prognostic Accuracy of Clinical Prediction Rules for Post-Pulmonary Embolism Mortality in Patients with Cancer

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Application of a Validated Predictive Model for Venous Thromboembolism in Cancer to Patients with Multiple Myeloma

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Risk Score For Venous Thromboembolism (VTE) In Ambulatory Patients: Impact Of Cancer Type and Risk Score On VTE Incidence, Early Mortality and Progression-Free Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only